{"product_id":"enterogermina-4-miliardi-5-ml-20-flaconcini","title":"Enterogermina 4 Billion\/5 Ml 20 Vials","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTreatment and prophylaxis of intestinal dysmicrobism and consequent endogenous vitamin deficiency. Therapy assists the restoration of the intestinal microbial flora, altered during antibiotic or chemotherapy treatments. Acute and chronic gastrointestinal disorders in infants, attributable to intoxications or intestinal dysmicrobisms and vitamin deficiency.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOne vial contains the active ingredient: polyantibiotic resistant Bacillus clausii spores (SIN, O\/C, T, N\/R strains) 4 billion. For the full list of excipients, see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVials: Purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDosage Adults: 1 vial per day. Infants and children: 1 vial per day. Method of administration Take the contents of the vial as is or diluted in water or other drinks (e.g. milk, tea, orange juice). This medicine is for oral use only. Do not inject or administer in any other way (see section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore below 30°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eSpecial warnings\u003c\/i\u003e Bacteremia\/sepsis Post-marketing cases of bacteremia, septicemia and sepsis have been reported in immunocompromised or seriously ill patients and in preterm infants. In the case of some critically ill patients, the outcome was fatal. ENTEROGERMINA should be avoided in these patient groups (see section 4.8). This medicine is for oral use only. Do not inject or administer by other routes. Incorrect use of the medicine has caused serious anaphylactic reactions such as anaphylactic shock. \u003ci\u003ePrecautions for use\u003c\/i\u003e During antibiotic therapy it is advisable to administer the preparation in the interval between one antibiotic administration and the next. The possible presence of visible corpuscles in the vials of ENTEROGERMINA is due to aggregates of spores of \u003ci\u003eBacillus clausii\u003c\/i\u003e; it is therefore not an indication of an altered product. Shake the vial before use.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo interaction studies have been performed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following side effects have been observed during treatment with this medicine, classified according to the MedDRA classification by organ class and according to the following frequency classes: very common (≥1\/10); common (≥1\/100,\u003c1\/10); uncommon (≥1\/1,000, \u003c1\/100); rare (≥1\/10,000,\u003c1\/1,000); very rare \u003c1\/10,000); not known (frequency cannot be estimated from the available data).\u003c\/p\u003e\n\u003cp\u003eInfections and infestations - Not known: Bacteremia, septicemia and sepsis (in immunocompromised or seriously ill patients) (see section 4.4).\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders - Not known: hypersensitivity reactions, including rash, urticaria and angioedema.\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eReporting of suspected adverse reactions. \u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at \u003cu\u003ehttps:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/u\u003e.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of overdose have been reported.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e There are no data available regarding the use of Enterogermina in pregnant women; therefore it is not possible to draw conclusions on the safety of the use of Enterogermina during pregnancy. Enterogermina should be used during pregnancy only if the potential benefits to the mother outweigh the potential risks, including those to the fetus. \u003cu\u003eBreastfeeding\u003c\/u\u003e There are no data available regarding the use of Enterogermina during breastfeeding regarding the composition of breast milk and the effects on the baby. It is not possible to draw any conclusions about the safety of using Enterogermina during breastfeeding. Enterogermina should be used during breastfeeding only if the potential benefits to the mother outweigh the potential risks, including those to the breast-fed baby. \u003cu\u003eFertility\u003c\/u\u003e No data are available on the effect of Enterogermina on human fertility.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEnterogermina does not alter the ability to drive or use machines.\u003c\/p\u003e","brand":"Sanofi","offers":[{"title":"Default Title","offer_id":40207823798387,"sku":"013046089","price":25.02,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/sanofi-spa-enterogermina-4-miliardi-5-ml-20-flaconcini-farmacia-dottor-tili-1213792750.webp?v=1767125928","url":"https:\/\/www.dottortili.com\/en-eu\/products\/enterogemine-4-billion-5-ml-20-vials","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}